Autoimmune Atrial Fibrillation or Atrial Fibrillation–Induced Autoimmunity? A New Atrial Fibrillation Begets Atrial Fibrillation Pathway?

HomeCirculationVol. 148, No. 6Autoimmune Atrial Fibrillation or Atrial Fibrillation–Induced Autoimmunity? A New Atrial Fibrillation Begets Atrial Fibrillation Pathway? No AccessEditorialRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessEditorialRequest AccessFull TextAutoimmune Atrial Fibrillation or Atrial Fibrillation–Induced Autoimmunity? A New Atrial Fibrillation Begets Atrial Fibrillation Pathway? Vincent Algalarrondo and Fabrice Extramiana Vincent AlgalarrondoVincent Algalarrondo Correspondence to: Vincent Algalarrondo, MD, PhD, Service de Cardiologie, Unité de Rythmologie, Hôpital Bichat Claude Bernard, 46 Bd Henri Huchard, 75018, Paris, France. Email E-mail Address: [email protected] Service de Cardiologie, Unité de Rythmologie, Hôpital Bichat Claude Bernard, Assistance Publique - Hôpitaux de Paris,, Paris, France (V.A., F.E.). Université de Paris Cité, France (V.A., F.E.). Search for more papers by this author and Fabrice ExtramianaFabrice Extramiana https://orcid.org/0000-0001-8123-4842 Service de Cardiologie, Unité de Rythmologie, Hôpital Bichat Claude Bernard, Assistance Publique - Hôpitaux de Paris,, Paris, France (V.A., F.E.). Université de Paris Cité, France (V.A., F.E.). Search for more papers by this author Originally published7 Aug 2023https://doi.org/10.1161/CIRCULATIONAHA.123.063672Circulation. 2023;148:499–501This article is a commentary on the followingAutoimmune Atrial FibrillationFootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.For Sources of Funding and Disclosures, see page 501.Circulation is available at www.ahajournals.org/journal/circCorrespondence to: Vincent Algalarrondo, MD, PhD, Service de Cardiologie, Unité de Rythmologie, Hôpital Bichat Claude Bernard, 46 Bd Henri Huchard, 75018, Paris, France. Email vincent.[email protected].frREFERENCES1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan G-A, Dilaveris PE, et al; ESC Scientific Document Group. ESC Scientific Document Group. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).Eur Heart J. 2021; 42:373–498. doi: 10.1093/eurheartj/ehaa612CrossrefMedlineGoogle Scholar2. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, et al; ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Circulation. 2014; 130:2071–2104. doi: 10.1161/CIR.0000000000000040LinkGoogle Scholar3. Heijman J, Algalarrondo V, Voigt N, Melka J, Wehrens XHT, Dobrev D, Nattel S. The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis.Cardiovasc Res. 2016; 109:467–479. doi: 10.1093/cvr/cvv275CrossrefMedlineGoogle Scholar4. Disertori M, Latini R, Barlera S, Franzosi MG, Staszewsky L, Maggioni AP, Lucci D, Di Pasquale G, Tognoni G; GISSI-AF Investigators. Valsartan for prevention of recurrent atrial fibrillation.N Engl J Med. 2009; 360:1606–1617. doi: 10.1056/NEJMoa0805710CrossrefMedlineGoogle Scholar5. Lazzerini PE, Capecchi PL, El-Sherif N, Laghi-Pasini F, Boutjdir M. Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies.J Am Heart Assoc. 2018; 7:e010595. doi: 10.1161/JAHA.118.010595LinkGoogle Scholar6. Tilly MJ, Geurts S, Zhu F, Bos MM, Ikram MA, de Maat MPM, de Groot NMS, Kavousi M. Autoimmune diseases and new-onset atrial fibrillation: a UK Biobank study.Europace. 2023;25:804–811. doi: 10.1093/europace/euac244CrossrefGoogle Scholar7. Yalcin MU, Gurses KM, Kocyigit D, Kesikli SA, Ates AH, Evranos B, Yorgun H, Sahiner ML, Kaya EB, Oto MA, et al. Elevated M2-muscarinic and β1-adrenergic receptor autoantibody levels are associated with paroxysmal atrial fibrillation.Clin Res Cardiol. 2015; 104:226–233. doi: 10.1007/s00392-014-0776-1CrossrefMedlineGoogle Scholar8. Maguy A, Mahendran Y, Tardif J-C, Busseuil D, Li J. Autoimmune atrial fibrillation.Circulation. 2023; 148:487–498. doi: 10.1161/CIRCULATIONAHA.122.062776LinkGoogle Scholar9. Ludwig RJ, Vanhoorelbeke K, Leypoldt F, Kaya Z, Bieber K, McLachlan SM, Komorowski L, Luo J, Cabral-Marques O, Hammers CM, et al. Mechanisms of autoantibody-induced pathology.Front Immunol. 2017; 8:603. doi: 10.3389/fimmu.2017.00603CrossrefMedlineGoogle Scholar10. Nagele EP, Han M, Acharya NK, DeMarshall C, Kosciuk MC, Nagele RG. Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease.PLoS One. 2013; 8:e60726. doi: 10.1371/journal.pone.0060726CrossrefMedlineGoogle Scholar11. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.Circulation. 1995; 92:1954–1968. doi: 10.1161/01.cir.92.7.1954LinkGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsRelated articlesAutoimmune Atrial FibrillationAnge Maguy, et al. Circulation. 2023;148:487-498 August 8, 2023Vol 148, Issue 6 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.123.063672PMID: 37549207 Originally publishedAugust 7, 2023 KeywordsautoimmunityEditorialsatrial fibrillationPDF download Advertisement SubjectsArrhythmiasAtrial FibrillationBasic Science ResearchElectrophysiologyTranslational Studies